NG

Nidhi Goyal

Active Director Director DIN 10677197
DIN 10677197 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Nidhi Goyal

Data last updated:

Nidhi Goyal is a Director at Nikolai Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Nikolai Pharmaceuticals Private Limited reported revenue of ₹7.1 Lakh (FY 2025).

DIN 10677197
Primary Designation Director
Industry Pharma
First Appointment 21 Jun 2024
Oldest Company Age 2 yrs
Largest company Nikolai Pharmaceuticals Private Limited · ₹7.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20242024₹7.1 Lakh (FY 2025)Active

Board colleagues of Nidhi Goyal

NameDINCompanyDesignation
Amit Goyal10677198Nikolai Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nikolai Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nidhi Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nidhi Goyal

Nidhi Goyal currently holds 1 directorship: Nikolai Pharmaceuticals Private Limited (Director, since 21 Jun 2024, revenue ₹7.1 Lakh (FY 2025)).

Nidhi Goyal was first appointed on 21 Jun 2024 as Director at Nikolai Pharmaceuticals Private Limited.

The current boards of Nidhi Goyal's companies include Amit Goyal (Nikolai Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available